Schedule 13G ownership disclosure

Diffusion Pharmaceuticals Inc.

Security class unavailable · CUSIP: 253748107

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,835,985
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-094327
Form type
SC 13G/A
Filer
Ally Bridge Group Capital Partners II, L.P.
CIK
CIK 1609313
Filed
Feb 05, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub